SELLAS Life Sciences (SLS) Operating Expenses (2020 - 2023)
Historic Operating Expenses for SELLAS Life Sciences (SLS) over the last 7 years, with Q4 2023 value amounting to $8.2 million.
- SELLAS Life Sciences' Operating Expenses fell 1343.43% to $8.2 million in Q4 2023 from the same period last year, while for Sep 2024 it was $8.2 million, marking a year-over-year decrease of 7910.73%. This contributed to the annual value of $37.9 million for FY2023, which is 1183.0% down from last year.
- SELLAS Life Sciences' Operating Expenses amounted to $8.2 million in Q4 2023, which was down 1343.43% from $9.4 million recorded in Q3 2023.
- In the past 5 years, SELLAS Life Sciences' Operating Expenses ranged from a high of $17.7 million in Q1 2022 and a low of $4.1 million during Q1 2020
- Over the past 4 years, SELLAS Life Sciences' median Operating Expenses value was $8.1 million (recorded in 2021), while the average stood at $8.3 million.
- Per our database at Business Quant, SELLAS Life Sciences' Operating Expenses skyrocketed by 12322.22% in 2022 and then tumbled by 3639.13% in 2023.
- SELLAS Life Sciences' Operating Expenses (Quarter) stood at $6.1 million in 2020, then surged by 91.76% to $11.6 million in 2021, then fell by 18.7% to $9.4 million in 2022, then decreased by 13.43% to $8.2 million in 2023.
- Its Operating Expenses stands at $8.2 million for Q4 2023, versus $9.4 million for Q3 2023 and $9.0 million for Q2 2023.